Clinical Trials Network: Pacific Northwest Node

这是加入NIDA的太平洋西北(PNW)节点的竞争续订申请 2001年1月，全国药物滥用治疗临床试验网络(CTN)。我们的主要目标是 继续积极支持CTN的使命，即“提高药物滥用治疗的质量” 以科学为载体的国家“通过开展行为、药理学和 在严格的多地点临床试验中整合行为-药物治疗干预措施 确定其在广泛的CTP设置和多样化的患者群体中的有效性 确保将研究成果转让给治疗提供者。 为了有效实现这些目标，(PNW)节点提议： 在研究人员、治疗人员之间保持有效的双向伙伴关系和工作关系 提供者和政策制定者 维护和扩大高度成功和成熟的治疗研究基础设施 节点 通过纳入基于社区的治疗计划(CTP)来扩大节点的地理覆盖范围 来自阿拉斯加，也扩大了Node内部的种族多样性 增强节点进行药物治疗试验的能力，并更快地对新出现的情况做出反应 通过增加更大的、高度研究经验的CTP来优先考虑公共卫生 ？通过增加多个附属公司，拓宽和深化Node的临床研究专业知识 直接从先前的主题领域干预试验中获得丰富经验的调查人员 与CTN相关 在过去的6年里，我们成功地为CTN的使命做出了贡献，并期待继续这样做 所以在未来。从公共卫生的角度来看，我们继续成功地进行这样的研究和 传播作为CTN的一部分，将促进经验支持的、循证的干预措施 在以社区为基础的治疗方案中实施，从而提高了质量和 药物滥用治疗的有效性。

This is a competing renewal application for the Pacific Northwest (PNW) Node, which joined the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN) in January, 2001. Our primary aim is to continue our active support of the CTN's mission, to "improve the quality of drug abuse treatmentthroughout the country using science as the vehicle" by conducting studies of behavioral, pharmacological, and ntegrated behavioral-pharmacological treatment interventions in rigorous, multi-site clinical trials to determine their effectiveness across a broad range of CTP settings and diversified patient populations and ensuring the transfer of research results to treatment providers. In order to effectively meet these objectives, the (PNW) Node proposes to: Maintain an effective, bidirectional partnership and working relationship among researchers, treatment providers, and policy makers Maintain and expand a highly successful and well-established treatment research infrastructure within the Node Expand the Node's geographical reach by incorporating a community-based treatment program (CTP) from Alaska, also broadening the ethnic diversity within the Node Enhance the Node's capacity to conduct pharmacotherapy trials and respond more rapidly to emerging public health priorities by adding a larger, highly research-experiencedCTP ¿ Broaden and deepen the clinical research expertise of the Node by adding a number of affiliated investigators who bring a wealth of experience from prior intervention trials on topic areas directly relevant to the CTN We have successfully contributed to the CTN's mission over the past 6 years and anticipate continuing to do so in the future. From a public health perspective, our continued success in conducting such research and dissemination as part of the CTN will facilitate empirically supported, evidence-based interventions being implemented in community-based treatment programs, with a resultant improvement in the quality and effectiveness of substance abuse treatment.